| III-41 Mita Thapar Population pharmacokinetic analysis of MSB11022 following administration in healthy subjects and rheumatoid arthritis patients. Thursday 09:55-11:20 |
| III-41 Mita Thapar Population pharmacokinetic analysis of MSB11022 following administration in healthy subjects and rheumatoid arthritis patients. Thursday 09:55-11:20 |